NEW YORK, NY / ACCESS Newswire / March 25, 2026 / RelationshipAdviceForum received Global Radiance Review's top prize, the ...
Advances Clinical Pipeline Across Dermatology, Urology, Oncology and strengthens Capital Base to support Phase 2 Programs PHILADELPHIA, PA / ACCESS Newswire / March 25, 2026 / Medicus Pharma Ltd. (NAS ...
New suite of purpose-built agents tackles root cause diagnosis, maintenance optimization, process optimization, and hazard ...
KUALA LUMPUR, MY / ACCESS Newswire / March 25, 2026 / Guan Huat Seng Holdings Berhad ("GHS Holdings" or the "Company") and ...
Trial demonstrated no safety concerns when co-administering roluperidone and olanzapine The Company continues to advance the program, with the confirmatory Phase 3 trial now enrolling and topline data ...
LOS ANGELES, CA / ACCESS Newswire / March 25, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals ...
Delivered flagship Tempo project, Brenmiller's first commercial-scale boiler replacement deployment, marking a major operational milestone in the Company's transition toward commercializationRecognize ...
Record Total Revenues, Same-Store Revenues and Net Operating Income with Sector-Leading Occupancy Driven by Continued Operational Excellence MILLBROOK, NY / ACCESS Newswire / March 25, 2026 / Global S ...
Revenue Rises 10% to $56.7M; Q4'25 Revenue Up 27% YoY to $15.6M2025 Net Loss Decreases by $9.5M and 2025 Adjusted EBITDA More than Triples to $2.9M compared to 2024Q4'25 Net Income of $1.0M vs. Net ...
Everest Group, Ltd. ("Everest" or "the Company") (NYSE: EG), a global specialty reinsurance and insurance leader, today announced the appointment of Jason Busti as Head of North America Treaty Reinsur ...
AI-Powered Workforce Management Platform Delivers NIST 800-171 Compliance and 3PAO-Validated FedRAMP Moderate Equivalency on AWS GovCloud IRVINE, CA / ACCESS Newswire / March 25, 2026 / Allied Univers ...
Completes Strategic Transformation into an Immunotherapy Company and Continues to Advance Entolimod Platform Toward Potential Funding PartnershipsConference Call to be Held Today at 1:30 PM PT / 4:30 ...